Bristol Myers Squibb’s (BMS) dual immunotherapy combination has been recommended by the European Medicines Agency’s human ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...
Cancer remains a major health challenge in India, ranking as the third leading cause of death after infectious and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback